Deferred Tax Assets, Net of Valuation Allowance of CytoDyn Inc. from 31 May 2019 to 31 May 2025

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: CytoDyn Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 May 2019 to 31 May 2025.
CytoDyn Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 May 2025 was $27,000, a 51% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

CytoDyn Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$27,000	-$28,000	-51%	31 May 2025	10-K	25 Jul 2025	2025	FY
Q2 2024	$55,000	-$29,000	-35%	31 May 2024	10-K	25 Jul 2025	2025	FY
Q2 2023	$84,000	+$84,000		31 May 2023	10-K	15 Aug 2024	2024	FY
Q2 2022	$0	$0		31 May 2022	10-K	14 Sep 2023	2023	FY
Q2 2021	$0	$0		31 May 2021	10-K	15 Aug 2022	2022	FY
Q2 2020	$0	$0		31 May 2020	10-K	30 Jul 2021	2021	FY
Q2 2019	$0			31 May 2019	10-K	14 Aug 2020	2020	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.